We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Viewpoint |

Should Life Insurers Have Access to Genetic Test Results?

Robert Klitzman, MD1; Paul S. Appelbaum, MD2; Wendy K. Chung, MD, PhD3
[+] Author Affiliations
1Masters of Bioethics Program, Columbia University Medical Center, New York, New York
2Department of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute, New York
3Departments of Pediatrics and Medicine, Columbia University, New York, New York
JAMA. 2014;312(18):1855-1856. doi:10.1001/jama.2014.13301.
Text Size: A A A
Published online


This Viewpoint discusses the issues involved in granting insurance companies access to consumers’ genetic information.

Should life insurance companies have access to consumers’ genetic information? In deciding whether to sell life insurance policies and at what price, insurers routinely consider applicants’ risk factors, such as smoking and obesity. Should genetic information be excluded? The Genetic Information Nondiscrimination Act (GINA) bars use of genetic information for health insurance underwriting decisions, but not for life, long-term care, or disability insurance. These questions have received occasional attention in the past but have become more salient with the rapidly decreasing cost and increasing use of predictive genetic testing. Individuals at risk for serious genetic diseases may fear loss of insurance coverage or higher rates and thus decline genetic testing that could improve disease prevention, early diagnosis, or treatment.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Multimedia

Author Reading

audio player

Articles Related By Topic
Related Collections
PubMed Articles